O'Connor SM, Taylor CE, Hughes JM. Emerging infectious determinants of chronic diseases. Emerging Infectious Diseases
2006; 12: 1051–1057.
Izadi M, et al.
Helicobacter species in the atherosclerotic plaques of patients with coronary artery disease. Cardiovascular Pathology
2012; 21: 307–311.
Melnick JL, et al.
Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. Journal of Medical Virology
1994; 42: 170–174.
Fraser NW, et al.
Herpes simplex type 1 DNA in human brain tissue. Proceedings of the National Academy of Sciences USA
1981; 78: 6461–6465.
Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet
1984; 1: 1311–1315.
Epstein SE. The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circulation Research
2002; 90: 2–4.
Kountouras J, et al.
Association between Helicobacter pylori infection and mild cognitive impairment. European Journal of Neurology
2007; 14: 976–982.
Tarter KD, et al.
Persistent viral pathogens and cognitive impairment across the lifecourse in the Third National Health and Nutrition Examination Survey. Journal of Infectious Diseases
2014; 209: 837–844.
Ferreira AC, et al.
Helicobacter and gastric malignancies. Helicobacter
2008; 13 (Suppl. 1): 28–34.
Soroceanu L, Cobbs CS. Is HCMV a tumor promoter?
2011; 157: 193–203.
Epstein SE, et al.
Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arteriosclerosis, Thrombosis, and Vascular Biology
2000; 20: 1417–1420.
Nazmi A, et al.
The influence of persistent pathogens on circulating levels of inflammatory markers: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis. BMC Public Health
2010; 10: 706.
Jackson L, et al.
A population-based epidemiologic study of Helicobacter pylori infection and its association with systemic inflammation. Helicobacter
2009; 14: 108–113.
Emerging Risk Factors Collaboration
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet
2010; 375: 132–140.
Simanek AM, Dowd JB, Aiello AE. Persistent pathogens linking socioeconomic position and cardiovascular disease in the US. International Journal of Epidemiology
2009; 38: 775–787.
Sealy-Jefferson S, et al.
Antibody levels to persistent pathogens and incident stroke in Mexican Americans. PLoS ONE
2013; 8: e65959.
Aiello AE, et al.
The influence of latent viral infection on rate of cognitive decline over 4 years. Journal of the American Geriatric Society
2006; 54: 1046–1054.
Aiello AE, et al.
Persistent infection, inflammation, and functional impairment in older latinos. Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
2008; 63: 610–618.
Jeon CY, et al.
Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care
2012; 35: 520–525.
Xia HH, et al.
Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. American Journal of Gastroenterology
2001; 96: 1039–1046.
Katan M, et al.
Infectious burden and cognitive function: the Northern Manhattan Study. Neurology
2013; 80: 1209–1215.
Miller GE, et al.
Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. American Journal of Cardiology
2005; 95: 317–321.
Fernandez-Real J-M, et al.
Burden of Infection and insulin resistance in healthy middle-aged men. Diabetes Care
2006; 29: 1058–1064.
Zhu J, et al.
Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. American Journal of Cardiology
2000; 85: 140–146.
Zhu J, et al.
Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation
2001; 103: 45–51.
Elkind MS, et al.
Infectious burden and risk of stroke: the northern Manhattan study. Archives of Neurology
2010; 67: 33–38.
Staras SA, et al.
Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clinical Infectious Diseases
2006; 43: 1143–1151.
Schillinger JA, et al.
National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976–1994. Sexually Transmitted Diseases
2004; 31: 753–760.
U.S. Department of Health and Human Services (DHHS). National Center for Health Statistics. Third National Health and Nutrition Examination Survey (NHANES III.: 1988–1994. NHANES III Second Laboratory File Documentation Series 11, No. 2A. Hyattsville, Maryland: Centers for Disease Control and Prevention, 1998.
SUDAAN. Example Manual, Release 10·0·1. Research Triangle Park, NC.: Research Triangle Institute, 2010.
Benjamini Y, Hochberg Y. Controlling the false discovery rate – a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B: Methodological
1995; 57: 289–300.
Sun Y, et al.
Herpes simplex virus type 2 infection is a risk factor for hypertension. Hypertension Research
2004; 27: 541–544.
de Luis DA, et al.
Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care
1998; 21: 1129–1132.
Thomas F, et al.
Herpes simplex virus type 2 and cancer: a medical geography approach. Infection, Genetics and Evolution
2011; 11: 1239–1242.
Beydoun MA, et al.
Helicobacter pylori seropositivity and cognitive performance among US adults: evidence from a large national survey. Psychosomatic Medicine
2013; 75: 486–496.
Colberg-Poley AM, Isom HC, Rapp F. Reactivation of herpes simplex virus type 2 from a quiescent state by human cytomegalovirus. Proceedings of the National Academy of Sciences USA
1979; 76: 5948–5951.
Colberg-Poley AM, Isom HC, Rapp F. Involvement of an early human cytomegalovirus function in reactivation of quiescent herpes simplex virus type 2. Journal of Virology
1981; 37: 1051–1059.
Strachan DP, et al.
Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study. British Medical Journal (Clinical Research Edition)
1999; 318: 1035–1039.